Arkolith/Insider Trading/APGE/Form 4

Dambkowski Carl

Chief Medical OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$391K
Net Open-Market Flow
-$391K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)2K$71.98$149K210K
Mar 4, 2026Sell(S)3K$70.33$227K212K
Mar 4, 2026Option exercise(M)4K$22.86$94K215K
Mar 4, 2026Sell(S)200$73.26$15K210K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)4K—$0131K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-024831) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML